Mirion Technologies, Inc. research snapshot
MIR AI stock analysis currently reads Mirion Technologies as a specialized provider of radiation detection, measurement, and monitoring solutions for nuclear energy, defense, medical imaging, and research end markets. At the July 12, 2026 data cutoff, the quoted price was $17.00, market capitalization was about $4.26 billion, and the stock was trading well below its 52-week high of $30.28 with a 52-week low of $15.58. All covering analysts rate the stock a Buy with an average target of $27.40. Q1 2026 results beat estimates with revenue of $257.6M and adjusted EPS of $0.10. This page is informational research and not investment advice.
Current price
$17.00
Market cap
$4.26 billion
AI score
62 / 100
Rating
Specialized radiation detection and measurement technology company serving nuclear, defense, medical, and research markets.
Trend status
Down from 52-week high, testing near support near the $15.58 low.
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Mirion provides mission-critical radiation detection and measurement technology with recurring service revenue and long-duration defense and nuclear contracts. | Medium-high |
| Moat | The moat comes from specialized technology, regulatory certifications, long-term government and nuclear utility contracts, and high switching costs in safety-critical applications. However, competition from larger defense contractors and emerging detection technologies remains a risk. | Medium |
| Management | Management has delivered consistent revenue growth and operational improvements since the SPAC merger. The Q1 2026 beat and raised visibility suggest execution is on track, though insider trading data was not fully available at this data cutoff. | Medium |
| Financial trend | Revenue has grown from roughly $222.9M (Jun 2025 quarter) to $257.6M (Mar 2026 quarter), with TTM revenue near $981M. Net income is positive on an adjusted basis but GAAP profitability remains thin with TTM GAAP net income near $25M. | Medium-high |
| Valuation | At $17.00 with adjusted EPS of $0.44, the forward P/E is around 38x. P/S is about 4.3x TTM revenue. Valuation is not obviously cheap but reflects growth expectations and nuclear/defense end-market tailwinds. | Medium |
| Technical trend | The stock is down about 44% from its 52-week high of $30.28 and near the low end of its range at $15.58. The price is below key moving averages with a recent -3.14% daily move on the cutoff day, suggesting weak near-term momentum. | Medium |
| Risk level | Key risks include U.S. federal budget cycles for defense and nuclear spending, the nuclear regulatory environment, GAAP profitability path, debt leverage post-SPAC, and customer concentration in government contracts. | Medium-high |
| AI confidence | High for revenue, market data, and analyst consensus from multiple verified sources. Lower for the intrinsic valuation range because the forward earnings trajectory depends on policy-driven end-market demand across nuclear, defense, and medical. | Medium |
| Investment certainty | Investment certainty is medium. Mirion has visible revenue, a beat track record, and favorable end-market tailwinds, but the 44% drawdown from the 52-week high, thin GAAP margins, and policy dependency keep conviction below high confidence. | Medium |
MIR AI stock forecast
The MIR AI stock forecast uses scenario ranges built from the three-scenario model using adjusted EPS of $0.44, consensus growth expectations, and peer-relative P/E bands. The model output guides the ranges, but actual prices can diverge because of policy changes, nuclear licensing cycles, defense budget shifts, and M&A activity.
$24 to $28
More likely if the company sustains 25% EPS growth driven by nuclear energy renaissance investments, defense budget increases, and operational leverage. A 30x forward P/E on three-year forward EPS near $0.86 would support this range. Analyst high target of $29 is consistent with this scenario.
$15 to $20
More likely if EPS grows at approximately 15% annually as the company benefits from steady nuclear and defense demand, maintains current margins, and trades near 22x forward EPS of about $0.67. This range is near the current price and offers a moderate risk-reward profile.
$6 to $12
More likely if revenue growth slows, defense budgets tighten, nuclear new-build timelines extend, or the company fails to convert revenue growth into sustainable GAAP profitability. A 12x multiple on slower 5% EPS growth would compress the stock substantially.
MIR AI technical analysis
MIR AI technical analysis starts from the $17.00 quote as of the July 12, 2026 data cutoff. The stock has declined significantly from the 52-week high of $30.28 and is testing the area near its 52-week low of $15.58. Volume on the cutoff day was 3.38 million, below the 4.27 million average, suggesting reduced participation. Live chart confirmation is needed before making trading decisions.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $17.00 | Current quote used for this page as of the July 12, 2026 data cutoff. |
| Near support | $15.58 to $16.50 | The 52-week low of $15.58 is the primary support. The $16.50 zone represents a psychological round number area where buyers may step in. |
| Near resistance | $18.50 to $20.00 | Near-term resistance from recent trading ranges. The $20 level is a psychological barrier after the stock broke below it in June 2026. |
| Major resistance | $24.00 to $30.28 | The 52-week high of $30.28 is the major upside reference. The $24 area was a prior support zone that now acts as resistance. |
| 50-day moving average | Requires live chart confirmation | Use current chart data before acting. The stock is likely below the 50-day SMA given the sustained downtrend from $30 to $17. |
| 200-day moving average | Requires live chart confirmation | Long-term trend confirmation should be checked against a live chart. The 200-day SMA is likely well above current price given the drawdown magnitude. |
| Momentum | Bearish with recent -3.14% daily move | The -3.14% daily decline on the cutoff date and position near the 52-week low indicate bearish near-term momentum. |
| Volume | 3.38M (below 4.27M average) | Below-average volume on the decline suggests selling may lack conviction, but it also shows no accumulation signal yet. |
| Volatility | Moderate-high with beta of 1.03 | Beta of 1.03 indicates volatility approximately in line with the broader market, but the 44% drawdown shows stock-specific risk is elevated. |
| Invalidation | Close below $15.58 | A decisive close below the 52-week low of $15.58 would open the door to further downside. A close above $20 with volume would be the first bullish signal. |
MIR AI trading strategy
The MIR AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and monitoring of nuclear policy, defense budgets, and quarterly earnings results.
In a confirmed downtrend, wait for MIR to stabilize above $18.50 with volume above the 4.27M average before considering a trend reversal. A close above $20 would strengthen the reversal case.
A close below the $15.58 52-week low or Q3 2026 earnings with disappointing revenue would invalidate any early reversal signal.
If MIR approaches or tests the $15.58 52-week low without a fundamental thesis break, compare price action with the next quarterly filing, defense budget news, and nuclear energy policy developments.
Do not average down without a predefined maximum loss. The stock has fallen 44% from its high, so catching a falling knife is a real risk without clear catalyst identification.
Track the evidence that matters most for Mirion: quarterly revenue growth, backlog trends, adjusted EBITDA margin progression, free cash flow conversion, GAAP profitability timeline, and nuclear/defense end-market announcements.
Reduce confidence if revenue growth decelerates below 10%, margins compress, or the company misses guidance after a string of beats.
Investment research summary
Mirion provides radiation detection, measurement, and monitoring equipment and services. Customers including nuclear power plants, defense agencies, hospitals, and research labs pay for safety-critical technology that must meet rigorous regulatory and certification standards.
The moat comes from regulatory certifications, long-term government and utility contracts, specialized radiation detection IP, installed base with recurring service revenue, and high switching costs in safety-critical environments where equipment failure is not tolerated.
The thesis can fail if nuclear energy investment slows under a policy shift, defense budgets face cuts, the company loses a key government contract, GAAP profitability stays elusive, debt servicing pressures cash flow, or competition from larger defense primes intensifies.
Management has demonstrated execution capability with consistent revenue growth and a Q1 2026 beat on both revenue and EPS. Capital allocation priorities include organic growth investment, debt management post-SPAC, and potential M&A in adjacent detection technologies.
Nuclear energy is experiencing a renaissance driven by AI data center power demand, clean energy policy, and small modular reactor development. Defense spending remains elevated globally. Medical imaging and radiation therapy continue to grow with aging populations and technology advances. These trends are broadly favorable for Mirion.
At $17.00, MIR trades at about 38x adjusted EPS and 4.3x revenue. The margin of safety is limited if growth disappoints. The bearish scenario suggests a downside to $6-$12 if EPS growth slows and multiples compress. The bullish case to $24-$28 requires sustained execution and favorable end-market conditions.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| MIR price | $17.00 | Google Finance quote snapshot | July 12, 2026 |
| Market capitalization | $4.26 billion, verified from Barchart share count of 250.42M shares at $17.00 | Barchart and Google Finance market cap cross-reference | July 12, 2026 |
| Shares outstanding | Approximately 250.42 million (Barchart) | Barchart key statistics | July 12, 2026 |
| TTM revenue (trailing 4 quarters) | Approximately $981 million (sum of quarterly data) | Google Finance quarterly income statement | July 12, 2026 |
| Adjusted EPS (TTM) | $0.44 | Barchart key statistics | July 12, 2026 |
| P/E ratio (TTM) | Approximately 38.6x on adjusted EPS of $0.44 | Calculated from Barchart EPS data | July 12, 2026 |
| 52-week range | $15.58 - $30.28 | Google Finance and Barchart | July 12, 2026 |
| Analyst consensus | 11 Buy, 0 Hold, 0 Sell. Avg target $27.40, range $25-$29 | Google Finance analyst ratings and Barchart | July 12, 2026 |
| Q1 2026 results | Revenue $257.6M, EPS $0.10, beat estimates of $244.77M and $0.09 | Google Finance earnings data | July 12, 2026 |
| Price-to-sales ratio | Approximately 4.3x TTM revenue | Calculated from Barchart revenue data | July 12, 2026 |
This MIR AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 12, 2026, may be incomplete, and can be wrong if new filings, government policy changes, nuclear energy investment trends, defense budget decisions, quarterly earnings, market prices, or macro conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
